GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kissei Pharmaceutical Co Ltd (OTCPK:KSPHF) » Definitions » Shiller PE Ratio

Kissei Pharmaceutical Co (Kissei Pharmaceutical Co) Shiller PE Ratio : 19.39 (As of May. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Kissei Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-27), Kissei Pharmaceutical Co's current share price is $22.88. Kissei Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 was $1.18. Kissei Pharmaceutical Co's Shiller PE Ratio for today is 19.39.

The historical rank and industry rank for Kissei Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

KSPHF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.95   Med: 18.22   Max: 29.41
Current: 18.35

During the past years, Kissei Pharmaceutical Co's highest Shiller PE Ratio was 29.41. The lowest was 14.95. And the median was 18.22.

KSPHF's Shiller PE Ratio is ranked better than
65.98% of 535 companies
in the Drug Manufacturers industry
Industry Median: 24.51 vs KSPHF: 18.35

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Kissei Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.411. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $1.18 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kissei Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Kissei Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kissei Pharmaceutical Co Shiller PE Ratio Chart

Kissei Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.24 18.29 16.59 15.42 -

Kissei Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.42 16.50 19.00 17.70 -

Competitive Comparison of Kissei Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kissei Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Kissei Pharmaceutical Co's Shiller PE Ratio falls into.



Kissei Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Kissei Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=22.88/1.18
=19.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kissei Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Kissei Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.411/106.8000*106.8000
=0.411

Current CPI (Dec. 2023) = 106.8000.

Kissei Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.072 95.700 0.080
201406 0.432 98.000 0.471
201409 0.404 98.500 0.438
201412 0.496 97.900 0.541
201503 -0.049 97.900 -0.053
201506 0.374 98.400 0.406
201509 0.286 98.500 0.310
201512 0.817 98.100 0.889
201603 -0.116 97.900 -0.127
201606 0.550 98.100 0.599
201609 0.212 98.000 0.231
201612 0.556 98.400 0.603
201703 0.125 98.100 0.136
201706 0.392 98.500 0.425
201709 0.407 98.800 0.440
201712 0.691 99.400 0.742
201803 0.200 99.200 0.215
201806 0.533 99.200 0.574
201809 0.114 99.900 0.122
201812 0.178 99.700 0.191
201903 0.233 99.700 0.250
201906 0.399 99.800 0.427
201909 0.027 100.100 0.029
201912 0.273 100.500 0.290
202003 -0.144 100.300 -0.153
202006 0.343 99.900 0.367
202009 0.541 99.900 0.578
202012 0.421 99.300 0.453
202103 -0.230 99.900 -0.246
202106 0.718 99.500 0.771
202109 0.398 100.100 0.425
202112 0.220 100.100 0.235
202203 1.116 101.100 1.179
202206 0.265 101.800 0.278
202209 0.256 103.100 0.265
202212 0.537 104.100 0.551
202303 0.626 104.400 0.640
202306 0.502 105.200 0.510
202309 0.356 106.200 0.358
202312 0.411 106.800 0.411

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kissei Pharmaceutical Co  (OTCPK:KSPHF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Kissei Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Kissei Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kissei Pharmaceutical Co (Kissei Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kissei Pharmaceutical Co (Kissei Pharmaceutical Co) Headlines

No Headlines